Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2816571

N.N.N.N.N.N.OB(O)OC(c1ccccc1)(c1ccccc1)c1ccccc1.OB(O)OC(c1ccccc1)(c1ccccc1)c1ccccc1.OB(O)OC(c1ccccc1)(c1ccccc1)c1ccccc1.[Co]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.38
ALDH1A1 P00352 3/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.34
KCNN4 O15554 2/20 0.33
TSHR P16473 2/20 0.33
TRPV6 Q9H1D0 2/20 0.33
CYP2C19 P33261 2/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
ENPP2 Q13822 1/20 0.33
CA14 Q9ULX7 1/20 0.33
CA5B Q9Y2D0 1/20 0.33
PCSK9 Q8NBP7 1/20 0.33
ORAI1 Q96D31 1/20 0.33
ORAI2 Q96SN7 1/20 0.33
ORAI3 Q9BRQ5 1/20 0.33
HIF1A Q16665 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL723986 0.95 KIF11 (0.40) KIF11ALDH1A1ALOX15MAPK1KCNN4
Benzene SCHEMBL27568485 0.95 KIF11 (0.40) KIF11ALDH1A1ALOX15MAPK1KCNN4
Tetramethylammonium Ion SCHEMBL8397669 0.87 ALDH1A1 (0.39) KIF11ALDH1A1ALOX15MAPK1KCNN4
SCHEMBL28419769 0.81 KIF11 (0.40) KIF11ALDH1A1ALOX15MAPK1KCNN4
Tetrylammonium SCHEMBL8395767 0.81 CHRM2 (0.37) KIF11ALDH1A1ALOX15MAPK1KCNN4
Ammonia Solution, Strong SCHEMBL9347147 0.80 ALDH1A1 (0.37) KIF11ALDH1A1ALOX15MAPK1KCNN4
Ammonia Solution, Strong SCHEMBL9771960 0.78 ALDH1A1 (0.34) KIF11ALDH1A1MAPK1CYP2C9
Ammonia Solution, Strong SCHEMBL9771953 0.78 ALDH1A1 (0.34) KIF11ALDH1A1MAPK1CYP2C9
SCHEMBL1333551 0.77 ALDH1A1 (0.39) KIF11ALDH1A1ALOX15MAPK1KCNN4
Choline SCHEMBL9687698 0.77 LMNA (0.38) KIF11ALDH1A1ALOX15CYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9126231-B2 Insulation pattern-forming method and insulation pattern-forming material JSR CORPORATION (JP) 2015-09-08 US disclosed
US-20130084394-A1 INSULATION PATTERN-FORMING METHOD AND INSULATION PATTERN-FORMING MATERIAL JSR CORPORATION (JP) 2013-04-04 US disclosed
US-20100244328-A1 CURABLE COMPOSITION FOR PHOTOIMPRINT, AND METHOD FOR PRODUCING CURED PRODUCT USING SAME FUJIFILM CORPORATION (JP) 2010-09-30 US disclosed
US-20100178620-A1 INVERTED PATTERN FORMING METHOD AND RESIN COMPOSITION JSR CORPORATION (JP) 2010-07-15 US disclosed
US-20100133728-A1 CURABLE COMPOSITION FOR PHOTOIMPRINT, AND METHOD FOR PRODUCING CURED PRODUCT USING SAME FUJIFILM CORPORATION (JP) 2010-06-03 US disclosed
US-20100121013-A1 CURABLE COMPOSITION FOR PHOTOIMPRINT, ITS CURED PRODUCT AND PRODUCTION METHOD FOR IT, AND COMPONENT OF LIQUID-CRYSTAL DISPLAY DEVICE FUJIFILM CORPORATION (JP) 2010-05-13 US disclosed
US-20090155546-A1 FILM-FORMING COMPOSITION, METHOD FOR PATTERN FORMATION, AND THREE-DIMENSIONAL MOLD TOKYO OHKA KOGYO CO., LTD. (JP) 2009-06-18 US disclosed
US-20090011367-A1 INTERFACE BINDER, RESIST COMPOSITION CONTAINING THE SAME, LAMINATE FOR FORMING MAGNETIC RECORDING MEDIUM HAVING LAYER CONTAINING THE SAME, MANUFACTURING METHOD OF MAGNETIC RECORDING MEDIUM USING THE SAME, AND MAGNETIC RECORDING MEDIUM PRODUCED BY THE MANUFACTURING METHOD FUJIFILM CORPORATION (JP) 2009-01-08 US disclosed
US-20060263702-A1 Composition for forming intermediate layer containing sylylphenylene-based polymer and pattern-forming method TOKYO OHKA KOGYO CO., LTD. (JP) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100121013-A1 CURABLE COMPOSITION FOR PHOTOIMPRINT, ITS CURED PRODUCT AND PRODUCTION METHOD FOR IT, AND COMPONENT OF LIQUID-CRYSTAL DISPLAY DEVICE MBTD1, CRY1, CCNT1 KIF11 1540/4885ALDH1A1 647/4885ALOX15 2714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.